This is a community-generated profile. If you would like to claim it, please .
Inviragen Funding
$15M
11 round
Inviragen is active in the following markets / industries: biotechnology. The company has secured funding across 1 rounds, totaling in an amount of $15M. Their most recent funding was raised on October 6, 2009.
Funding Rounds
A
$15000000Series AOct 2009
Investors of Inviragen
Michael Schump
Bio- and med- tech investor.
Charter Life Sciences
Rounds
A
Bio*One Capital
Rounds
A